Literature DB >> 32253422

HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.

Kazuya Sakai1, Masataka Kuwana2, Hidenori Tanaka3, Kazuyoshi Hosomichi4, Atsushi Hasegawa5, Hiroki Uyama6, Kenji Nishio7, Takashi Omae8, Masakatsu Hishizawa9, Masashi Matsui10, Koji Iwato11, Akinao Okamoto12, Kazuki Okuhiro13, Yukiko Yamashita14, Masataka Itoh15, Hanae Kumekawa16, Naoki Takezako17, Noriaki Kawano18, Toshihiro Matsukawa19, Haruna Sano20, Kazuiku Ohshiro21, Kunio Hayashi22, Yasunori Ueda23, Toshiki Mushino24, Yoshiyuki Ogawa25, Yuji Yamada26, Mitsuru Murata27, Masanori Matsumoto1.   

Abstract

Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare autoimmune disorder caused by neutralizing anti-ADAMTS13 autoantibodies. In white individuals, HLA allele DRB1*11 is a predisposing factor for iTTP, whereas DRB1*04 is a protective factor. However, the role of HLA in Asians is unclear. In this study, we analyzed 10 HLA loci using next-generation sequencing in 52 Japanese patients with iTTP, and the allele frequency in the iTTP group was compared with that in a Japanese control group. We identified the following HLA alleles as predisposing factors for iTTP in the Japanese population: DRB1*08:03 (odds ratio [OR], 3.06; corrected P [Pc] = .005), DRB3/4/5*blank (OR, 2.3; Pc = .007), DQA1*01:03 (OR, 2.25; Pc = .006), and DQB1*06:01 (OR,: 2.41; Pc = .003). The estimated haplotype consisting of these 4 alleles was significantly more frequent in the iTTP group than in the control group (30.8% vs 6.0%; Pc < .001). DRB1*15:01 and DRB5*01:01 were weak protective factors for iTTP (OR, 0.23; Pc = .076; and OR, 0.23, Pc = .034, respectively). On the other hand, DRB1*11 and DRB1*04 were not associated with iTTP in the Japanese. These findings indicated that predisposing and protective factors for iTTP differ between Japanese and white individuals. HLA-DR molecules encoded by DRB1*08:03 and DRB1*11:01 have different peptide-binding motifs, but interestingly, bound to the shared ADAMTS13 peptide in an in silico prediction model.
© 2020 by The American Society of Hematology.

Entities:  

Year:  2020        PMID: 32253422     DOI: 10.1182/blood.2020005395

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity.

Authors:  Anja Panhuber; Giovanni Lamorte; Veronica Bruno; Hakan Cetin; Wolfgang Bauer; Romana Höftberger; Astrid C Erber; Florian Frommlet; Inga Koneczny
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

Review 2.  Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature.

Authors:  Kaori Uchino; Kazuya Sakai; Saki Shinohara; Akifumi Matsuhisa; Yusuke Iida; Yuta Nakano; Saori Matsumura; Jo Kanasugi; Soichi Takasugi; Ayano Nakamura; Tomohiro Horio; Satsuki Murakami; Shohei Mizuno; Hidesuke Yamamoto; Ichiro Hanamura; Masanori Matsumoto; Akiyoshi Takami
Journal:  Int J Hematol       Date:  2022-03-10       Impact factor: 2.319

Review 3.  Emerging Concepts in Immune Thrombotic Thrombocytopenic Purpura.

Authors:  Aicha Laghmouchi; Nuno A G Graça; Jan Voorberg
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.